Statistics for Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
Total visits
| views | |
|---|---|
| Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | 1 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:67932657-8cb5-423c-9808-bbe00d067482 | 22 |
| java.util.UUID:afe2b04f-57c7-423d-807f-8306e393cf4f | 18 |
| java.util.UUID:6f7cf4dc-5b02-41ee-b8c0-1c2d3e4d7c03 | 4 |
| Zambrano2022Effectiveness-PubP.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 1 |
Top city views
| views | |
|---|---|
| Indianapolis | 1 |